Oxford COVID-19 clinical trial aims for a viable vaccine by September
A team at Britain's Oxford University is starting human trials on a potential COVID-19 vaccine on Thursday, Health Minister Matt Hancock announced Tuesday, and the British government is "going to back them to the hilt," starting with a $25 million government investment.
Oxford's Jenner Institute and the Oxford Vaccine Group are conducting the trial. Adrian Hill, director of Jenner Institute, said last week the "aim is to have about a million doses by September once we have the results of our vaccine efficacy tests," and "then we'll move even faster from there, because it's pretty clear that the world is going to need hundreds of millions of doses ideally by the end of the year to end this pandemic." The Oxford team is trialing an experimental recombinant viral vector vaccine called "ChAdOx1 nCoV-19," one of at least 70 vaccine candidates under development worldwide, though only four have been cleared for human testing.
Prof. Sarah Gilbert, who is leading the study, said her team was already working on coronavirus vaccines last year in preparation for an outbreak of "Disease X," so once the disease hit, they were able to work "unusually quickly." Infectious disease experts warn that a vaccine won't be available for 12 to 18 months, if ever, but while "we can never be certain that these vaccines will work," Gilbert said, "personally I think it has a very strong chance of working."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
If a vaccine has been deemed safe and effective, the world will need billions of doses, and Bill Gates is among those urging the world to prepare facilities to mass-produce whatever kind of vaccine emerges victorious. That will entail global cooperation, and the Oxford team says it will produce its initial million does at plants in Britain, Europe, India, and China. The U.S. doesn't have the capacity to make the 300 million-plus doses it will need, but the U.S. government could prepare by taking over liquor or beer plants and sterilizing their fermentation vats, medical historian Arthur Silverstein tells The New York Times. "Any distillery could be converted."
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
'Stormy Monday for Don'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
6 queer poets to read whenever but especially now
The Week Recommends April is National Poetry Month
By Scott Hocker, The Week US Published
-
How women's pain is often ignored in health care
the explainer The gap in care is especially glaring compared to how men are treated
By Theara Coleman, The Week US Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published